FIORENTINO, F.; DI RIENZO, P. Budget impact analysis of enzalutamide for the treatment of hormone-sensitive metastatic prostate cancer in Italy. Global and Regional Health Technology Assessment, [S. l.], v. 10, n. 1, p. 29–39, 2023. DOI: 10.33393/grhta.2023.2507. Disponível em: https://journals.aboutscience.eu/index.php/grhta/article/view/2507. Acesso em: 12 jul. 2024.